EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): C$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.18. In 2024 the company made an earnings per share (EPS) of C$0.19 an increase over its 2023 EPS that were of C$0.13.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	C$0.17	-8.49%
2024	C$0.19	42.43%
2023	C$0.13	8.77%
2022	C$0.12	-20.62%
2021	C$0.15	-26.59%
2020	C$0.21	27.24%
2019	C$0.17	28.41%
2018	C$0.13	20.04%
2017	C$0.11	31.21%
2016	C$0.08171	11.46%
2015	C$0.07330	36.27%
2014	C$0.05379	19.77%
2013	C$0.04491	18.05%
2012	C$0.03805	23.9%
2011	C$0.03071	26.9%
2010	C$0.02420	12.37%
2009	C$0.02154	56.6%
2008	C$0.01375	9.18%
2007	C$0.01260	114.48%
2006	C$0.005873	64.83%
2005	C$0.003563	35.55%
2004	C$0.002629	29.73%
2003	C$0.002026	19.86%
2002	C$0.001690	-2.71%
2001	C$0.001738	1.02%
2000	C$0.001720

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions